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ABSTRACT: Deficiency of the cysteine protease inhibitor cystatin M/E (Cst6) in mice leads to disturbed epidermal
cornification, impaired barrier function, and neonatal lethality.We report the rescue of the lethal skin phenotype of
ichq (Cst6-deficient; Cst62/2) mice by transgenic, epidermis-specific, reexpression of Cst6 under control of the
human involucrin (INV) promoter. Rescued Tg(INV-Cst6)Cst6ichq/ichqmice survive the neonatal phase, but display
severe eye pathology and alopecia after 4 mo. We observed keratitis and squamous metaplasia of the corneal
epithelium, comparable toCst62/2Ctsl+/2mice, aswehave reported inother studies.Wefound the INVpromoter to
beactive in thehair follicle infundibulum;however,wedidnot observeCst6proteinexpression in the lower regions
of the hair follicle in Tg(INV-Cst6)Cst6ichq/ichq mice. This result suggests that unrestricted activity of proteases is
involved in disturbance of hair follicle biology, eventually leading to baldness. Using quenched activity-based
probes, we identified mouse cathepsin B (CtsB), which is expressed in the lower regions of the hair follicle, as an
additional target of mouse Cst6. These data suggest that Cst6 is necessary to control CtsB activity in hair follicle
morphogenesis and highlight Cst6-controlled proteolytic pathways as targets for preventing hair loss.—Oortveld,
M. A. W., van Vlijmen-Willems, I. M. J. J., Kersten, F. F. J., Cheng, T., Verdoes, M., van Erp, P. E. J., Verbeek, S.,
Reinheckel,T.,Hendriks,W. J.A. J.,Schalkwijk, J.,Zeeuwen,P.L. J.M.CathepsinBasapotential cystatinM/E target
in the mouse hair follicle. FASEB J. 31, 4286–4294 (2017). www.fasebj.org
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CystatinM/E (CST6) is a cysteine protease inhibitor that is
mainly expressed in the epidermis,more specifically in the
upper layers of the stratum granulosum, sweat glands,
sebaceousglands, andhair follicles (HFs) (1–3), suggesting
an important role for CST6 in skin and hair physiology.
Ourprevious studieshave identifiedCST6asa component
in a novel biochemical pathway that controls skin
barrier formation by regulating both cornification and
desquamation of the stratum corneum (SC). CST6 plays a
key role in this pathway, as it controls the activity of both
the papain-like proteases cathepsin L (CtsL) and CTSV
and the asparaginyl endopeptidase legumain (LGMN) (4).
Furthermore, as human CTSL is the elusive enzyme that
processes andactivates human transglutaminase (TGM)-3
(4), CST6may regulate cross-linking of structural proteins
during the cornification process.
The importance of Cst6 and its target proteases in ter-
minal differentiation of the epidermis is illustrated by the
severe skin phenotype of the Cst6-deficient mouse (ichq,
referred to herein asCst62/2), characterizedby abnormal SC
and HF formation, disturbed skin barrier function, and
neonatal lethality (5–7). The lethal skin phenotype of the
Cst6-deficient mouse makes it impossible to study the con-
sequencesofCst6deficiency inadultanimals.Tocircumvent
this problem, we generated Cst62/2/Tgm32/2, Cst62/2/
Lgmn2/2, and Cst62/2Ctsl2/2 double-knockout mice and
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have shown that a tightly regulated balance between the
protease CtsL and Cst6 is essential for tissue integrity of the
epidermis and for maintenance of corneal epithelium (8).
BothCst62/2Ctsl2/2 andCst62/2Ctsl+/2mice are completely
bald, a phenomenon that thus could not be attributed to
deleterious effects of free CtsL activity and rather suggests
that there are hitherto unknown Cst6 targets in mice.
In the current study,we sought to identifypossible new
Cst6 targets by rescuing Cst6 deficiency in skin, using
classic transgenesis and analyzing the consequences of
Cst6 deficiency in other tissues. We found disturbance of
HF biology in adult rescued mice, most likely related to
unrestrictedprotease activity, asCst6 is absent in the lower
regions of the HF in these rescued mice. The data provide
evidence that cathepsin (Cts)-B represents a novel and
crucial Cst6 target in the mouse HF.
MATERIALS AND METHODS
Construction of the Cst6 expression vector
Total RNA from mouse tissues was isolated by using Trizol Re-
agent (Thermo Fisher Scientific, Waltham, MA, USA) (6). Oligo-
dT-primed single-strand cDNAwas synthesized from total RNA
by Moloney murine leukemia virus RNase-H2 reverse tran-
scriptase (Boehringer,Mannheim, Germany). To amplify the full
mouse Cst6 coding sequence, we used the following oligonu-
cleotide primers: forward, 59-CTGAATCCGCGGCTATG-
GAG-39 and reverse, 59-CCTGACTCTGTCACCCTGG-39
(corresponding to nt 13–32 and 483–501, respectively, in the
mouse Cst6 cDNA sequence; accession ID: MGI:1920970). PCR
conditions (1 mM MgCl2) were 94°C for 6 min followed by 35
cycles of 94°C for 1 min, 57°C for 1 min, and 72°C for 2 min.
The resulting mouse Cst6 cDNA fragment was cloned into the
pCR2.1-TOPO cloning vector (Thermo Fisher Scientific). The
Cst6 cDNA vector, together with the human involucrin (INV)
promoter-containing plasmid pBS-3700 (a kind gift from Dr.
Joseph M. Carroll, State University of New York, Stony Brook,
NY, USA), and the pIRES2-EGFP vector (BD Biosciences Clon-
tech, Mountain View, CA, USA), were used for construction of
the final Cst6 expression vector (pBS-INV-Cst6-IRES-eGFP).
First, pIRES2-EGFPwasmodified by inserting a BamHI adaptor
(59-TTAACGGGATCCCG-39) at the unique AflII site. Subse-
quently, the internal ribosomal entry site (IRES), enhanced green
fluorescent protein (eGFP), and simian virus 40 poly(A) signal
sequenceswere excisedwithBamHIand inserted into theunique
BamHI site in pBS-3700. Finally, the Cst6 coding sequence was
cloned into the intermediate vector with EcoRI, resulting in the
expression vector pBS-INV-Cst6-IRES-eGFP. All cloning steps
were examined by DNA sequence analysis.
Cell culture and transfection of
human keratinocytes
Human epidermal keratinocytes, obtained from abdominal
skin after surgical correction, were cultured in keratinocyte
growth medium (Lonza, Basel, Switzerland) (9). Transfection
of keratinocytes with pBS-INV-Cst6-IRES-eGFP or pIRES2-
eGFP was performed at 90–100% confluence, followed by
switching to keratinocyte growth medium/5% fetal calf se-
rum to stimulate keratinocyte differentiation. Transfections
were performed in OptiMEM I (Thermo Fisher Scientific),
with Lipofectamine 2000 (LF2000; Thermo Fisher Scientific),
according to themanufacturer’s protocol with a DNA:LF2000
ratio of 1 mg:5 ml. Finally, keratinocytes were harvested for
flow cytometry or RNA isolation, and the culture supernatant
was used for ELISA.
Detection of eGFP expression
Cultured keratinocytes were harvested and resuspended in PBS
and subsequently sorted on an EPICS Elite flow cytometer
(Coulter, Luton, United Kingdom) that detects fluorescent sig-
nals. Viable cells were separated from dead cells based on mor-
phology and amount of propidium iodide uptake and analyzed
for eGFP expression. In addition, keratinocyte suspensions were
analyzed directly by fluorescence microscopy.
Detection of Cst6 transgenic transcripts
RNA was isolated from cultured keratinocytes, treated with
DNase I (Thermo Fisher Scientific) to prevent DNA contamina-
tion, and used for cDNA synthesis as described above. Sub-
sequently, the cDNA templates were used in a PCR reaction for
amplification of the mouse Cst6 part of the construct. The PCR
(35 cycles) contained 2.5 mM MgCl2 and was performed at a
melting temperature of 61°Cwith the followingprimers: forward,
59-ATGGAGCGTCCTCACTTCC-39 and reverse, 59-CCTGACT-
CTGTCACCCTGG-39 (corresponding to nt 27–45 and 483–501,
respectively, in the mouseCst6 cDNA sequence; accession ID:
MGI:1920970). PCR products were analyzed on ethidium
bromide-stained 1.5% agarose gels.
ELISA for mouse Cst6
Recombinant mouse Cst6 and human CST6 (both from R&D
Systems,Minneapolis,MN,USA)wereusedasa standardandasa
negative control, respectively, in concentrations varying from 5 to
0.156 ng/ml. Thewells of a 96-well platewere coated overnight at
4°C with polyclonal rabbit anti-human CST6 antibody (2), fol-
lowed by incubation with 1% bovine serum albumin (ICN Bio-
medicals, Aurora, OH, USA) and 1% normal goat serum (Vector
Laboratories, Burlingame, CA, USA) in PBS for 30 min. Sub-
sequently, standards, controls, and samples (undiluted up to 323
diluted) were incubated for 1 h, followed by incubation with
monoclonal rat anti-mouse Cst6 (R&D Systems) in PBS/1% nor-
mal rabbit serum/0.1% bovine serum albumin/0.05% Tween-20
for 30 min. Next, wells were incubated with goat anti-rat bio-
tinylated antibody (Vector Laboratories) for 30min, followed by a
final incubation with avidin-biotinylated horseradish peroxidase
complex (Vector Laboratories) for 30 min. The above incubation
stepswere performed at 37°C and separated by repeatedwashing
steps with PBS/0.05% Tween-20. Chromogenic substrate 1-step
Ultra TMB (Thermo Fisher Scientific) was used as substrate for
detectionandthereactionwasstoppedbyadding4MH2SO4.Each
well was measured for mouse Cst6 at an absorbance of 450 nm
with an ELISAmicroplate reader (Bio-Rad, Hercules, CA, USA).
Microinjection of the transgene in mouse zygotes
The generation of transgenic mice was performed according to
standardprotocols (10) and theguidelines of the localCommittee
for Animal Welfare. The transgenic expression plasmid was
isolated from bacteria with an endotoxin-free midi-prep kit
(Sigma-Aldrich, St. Louis,MO,USA), followed by excision of the
INV-Cst6-IRES-eGFP transgene [Tg(INV-Cst6-IRES-eGFP)] with
SalI and SpeI restriction enzymes and subsequent purification of
the linearDNA fragment. Superovulationwas induced in female
C57BL/6Jmice and at 0.5 d after coitus themicewere euthanized
and the fertilized eggs (zygotes) collected. The transgene was
CYSTATIN M/E IN HAIR FOLLICLES 4287
Downloaded from www.fasebj.org by Radboud Universiteit Nijmegen Universiteitsbibliotheek 00009 (131.174.248.154) on April 18, 2019. The FASEB Journal Vol. ${article.issue.getVolume()}, No. ${article.issue.getIssueNumber()}, pp. 4286-4294.
microinjected into the male pronucleus, and surviving zygotes
were subsequently cultured in vitro overnight onto the 2-cell
stage.Viablemicroinjectedzygoteswere then transferred into the
oviduct of a 0.5 d postcoitus pseudopregnant female C57BL/6J
mouse to resume embryonic development.
Mice
We have reported that a null mutation in the Cst6 gene (Cst6)
causes the lethal skin phenotype of ichq/ichqmice,which harbor
a spontaneous mutation first described in BALB/cJ mice (6).
After they were backcrossed 6 times to C57BL/6J mice, the
C57BL/6J Cst6+/2 mice were cross-bred to the transgenic,
epidermis-specific Cst6-expressingmice to obtain the rescued
Tg(INV-Cst6)Cst6ichq/ichq mice. All mice were housed in spe-
cific-pathogen–free facilities at the Central Animal Labora-
tory (University of Nijmegen). All animal experiments were
approved by theUniversity ofNijmegen InstitutionalAnimal
Care and Use Committee.
Mouse genotyping
Tail tissue biopsies were collected, and samples were incubated
overnight at 55°C for cell lysis in 200 ml DirectPCR solution
(ViagenBiotech, LosAngeles, CA,USA) and 100ml proteinaseK
(0.5 mg/ml; Roche, Mannheim, Germany). Genomic DNA was
isolated by phenolchloroform extraction and alcohol pre-
cipitation. The genotyping PCR (42 cycles) contained 2.5 mM
MgCl2 andwasperformedat amelting temperature of 53°C.The
following primers were used to identify the transgene: forward
primer (exon 2) 59-TACTACCTGACTTTGGACATA-39 and re-
verse primer (exon 3) 59-AAAGTTGCAACGCAGTTT-39 (cor-
responding to nt 285–305 and 393–410, respectively, in the
mouse Cst6 cDNA sequence; accession ID: MGI:1920970). PCR
primers used to distinguish between the Cst6 wild-type (WT)
and mutant alleles were the following: forward primer 59-
GGATGGAAGTCCAGACAC-39 forboth alleles, reverse primer
59-AGGCAGAATGCGAGCAG-39 for the WT Cst6 allele; and
reverse primer 59-GAGGCAGAATGCGAGAA-39 for the mu-
tant Cst6 allele. PCR products were analyzed on ethidium
bromide-stained 1.5% agarose gels.
Histopathology and immunofluorescence staining
We collected dorsal skin and eyes from the offspring of both
founders in a time course, starting at wk 7 and continuing until
1 yr. Dorsal skin and eye were rinsed in PBS, fixed for 4 h in
buffered 4% formalin, and embedded in paraffin wax, from
which 7-mmsectionswere cut and stainedwith hematoxylin and
eosin (H&E) or analyzed by immunofluorescence (11). Primary
antibodies that were used in this studywere rabbit anti-human/
mouse loricrin and rabbit anti-human/mouse filaggrin (all from
Covance, Richmond, CA, USA), goat anti-human/mouse Cst6,
goat anti-mouse CtsB (both from R&D Systems), rabbit anti-
mouse Ki-67, rat anti-mouse CD34, rabbit polyclonal anti-
human/mouse eGFP, and chicken anti-human/mouse K15 (all
from Abcam, Cambridge, United Kingdom). For immunofluo-
rescence analysis, the following secondary reagents were used:
Alexa-Fluor 488 goat anti-rabbit IgG, highly cross-absorbed, and
Alexa-Fluor 594 goat anti-rat, goat anti-mouse, and chicken anti-
goat IgG, highly cross-absorbed (Thermo Fisher Scientific).
Cell culture and fluorescent quenched
activity-based probe labeling of cell lysates
Mouse monocyte macrophages (RAW cells) (12) and mouse
skin melanoma cells (B16-F10) (13) were cultured in DMEM
supplementedwith 10%fetal bovine serum, 100U/mlpenicillin,
and 100mg/ml streptomycin (all fromThermo Fisher Scientific).
Some 2 3 105 cells per condition were harvested, washed with
PBS, and resuspended in 10 ml citrate buffer per condition
[50 mM citrate buffer (pH 5.5), 5 mM DDT, 0.5% CHAPS, and
0.1% Triton X]. After 15 min on ice and centrifugation at 4°C for
30 min, the supernatants were collected. The lysate was in-
cubatedwith the followingprotease inhibitors; E-64, Z-FY (t-BU)
DMK (Calbiochem, San Diego, CA, USA), CA-074 (Brunschwig
Chemie, Amsterdam, The Netherlands), N-ethylmaleimide
(Sigma-Aldrich), DCG-04 (kindly provided to M. V. by Prof.
Hermen S. Overkleeft, Leiden University, Leiden, The Nether-
lands), and mouse Cst6 (R&D Systems) (203 DMSO in citrate
buffer) for 1 h at 37°C, followed by incubation with 1 mM of the
quenched activity-based probe (qABP) BMV109 (203 in DMSO)
for 1 h at 37°C (14). In the heat inactivated control, the lysatewas
heated for 5 min at 95°C before the addition of BMV109. SDS-
sample buffer (43) was added, and the protein was denatured
for 3 min at 95°C and resolved by SDS-PAGE (15%), and the
labeled proteases were visualized by scanning the gel with a
Typhoon Trio imager (GE Healthcare, Little Chalfont, United
Kingdom). Labeling intensities were quantified with ImageJ
software (National Institutes of Health, Bethesda, MD, USA).
Fluorometric enzyme assay
Protease inhibitor activity of recombinant mouse Cst6 (R&D
Systems) against recombinant mouse CtsB (R&D Systems) was
determined by measuring the hydrolysis of the fluorescent
Z-Leu-Arg-AMC substrate (R&D Systems) (4). Assays were
performed in a 25 mM 2-(N-morpholino)ethanesulfonic acid
buffer (pH 5.0). TheCtsB inhibitor CA-074 (BrunschwigChemie)




To generate transgenic, epidermis-specific Cst6-expressing
mice, we first constructed a vector inwhich the complete
mouse Cst6 coding sequence was placed under the
control of the INVpromoter and in front of an IRES-eGFP
cassette, to facilitate detection of transgene expression
(Supplemental Fig. 1A). INV is a structural epidermal
protein that is exclusively expressed in the suprabasal
layers of stratified squamous epithelium (15). Tovalidate
the construct, we transiently transfected human kerati-
nocytes, stimulated their differentiation, and analyzed
the relative number of eGFP+ cells by flow cytometry and
fluorescence microscopy (Supplemental Fig. 1B, C).
These pBS-INV-Cst6-IRES-eGFP–transfected keratino-
cytes also expressed mouse Cst6, as determined by
RT-PCR amplification of Cst6 coding sequences (Sup-
plemental Fig. 1D) and ELISAdetection ofmouseCst6 in
the keratinocyte culturemedium (Supplemental Fig. 1E).
Transgenic founder mice were created by microinjec-
tion of the transgene into C57BL/6J mouse zygotes. Gen-
otyping of resulting litters for endogenous and transgenic
Cst6 sequences was performed by PCR using exon-
spanning primers (not shown). Overexpression of Cst6
protein in the epidermis of the foundermice did not cause
an obvious skin phenotype (not shown). The resulting
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transgenic, epidermis-specific, Cst6-expressing founder
was subsequently cross-bred with Cst6+/2mice (breeding
schedule is depicted in Supplemental Fig. 2). The obtained
Tg(INV-Cst6-IRES-eGFP)Cst6ichq/ichq rescued mice were
viable, but developed hair and eye abnormalities as they
matured (Fig. 1A). Further breeding with these transgenic
rescued founders, from now on referred to as Tg(INV-
Cst6)Cst6ichq/ichq, demonstrated stable germline trans-
mission of the transgene in the resulting offspring. The
mice all showedkeratitis and a severe fur phenotype,with
complete loss of the HFs at;16wk of age.We notedwith
interest that the Tg(INV-Cst6)Cst6ichq/ichq mice developed
eye lashes and whiskers.
Keratitis and metaplasia of the corneal
epithelium in Tg(INV-Cst6)Cst6ichq/ichq mice
Microscopic analysis of affected eyes in Tg(INV-Cst6)
Cst6ichq/ichq mice revealed that from wk 20 onward, the
corneal epithelium became thickened, and keratitis was
apparent (Fig. 1B), resembling the eye phenotype that we
hadobserved in theCst62/2Ctsl+/2mice (8).The lattermice
also developed severe keratitis, thickening of the corneal
stroma, and squamous metaplasia of the corneal epithe-
lium, a particular phenotype in which the cornea starts to
resemble epidermis after about half a year. To investigate
whether this was also the case in Tg(INV-Cst6)Cst6ichq/ichq
mice, we analyzed expression of the cornified epithelium
markerproteins loricrin and filaggrin.As inCst62/2Ctsl+/2
mice, these proteins were aberrantly expressed in the
corneal epithelium of adult Tg(INV-Cst6)Cst6ichq/ichq mice
(Fig. 1C).
Disturbed HF biology in
Tg(INV-Cst6)Cst6ichq/ichq mice
A cyclic phenotype of periodic loss and regrowth of hair
was observed in Tg(INV-Cst6)Cst6ichq/ichq mice; however,
after 4 mo, these rescued mice remained bald. Immunos-
taining for Cst6 and INV (Fig. 2A) revealed that, in WT
mice, both proteins colocalized in the epidermis and in the
proximal part of theHF,whereasCst6 expressionwas also
observed in lower regions of the HF, including the area
around the bulge. Epithelial stem cells were readily de-
tected in the HF bulge area of WT mice upon staining for
the stem cell markers CD34 and keratin 15, and for the
proliferation marker Ki67 (Fig. 2B). However, we were
not able to detect cells that are positive for these markers
in the HFs of Tg(INV-Cst6)Cst6ichq/ichq mice. Histologic
analysis over a time course revealed that the HFs in
Tg(INV-Cst6)Cst6ichq/ichq mice disappeared as early as
from 11 wk onward (Fig. 2C). We did not observe an
increase in immune cells in the lower region of the HFs.
Mouse Cst6 targets CtsB in the HF
As complete baldness is also observed in Cst62/2Ctsl2/2
mice (8), the hair loss in Tg(INV-Cst6)Cst6ichq/ichq rescued
mice cannot be caused by unrestricted CtsL activity. We
hypothesized that there must be another target protease
for Cst6 that is responsible for destruction of the HFs. To
identify such candidate proteases we used a qABP,
BMV109 (14), which becomes fluorescent upon covalently
binding to active cysteine cathepsins. Cell lysates of RAW
cells were preincubated with recombinant mouse Cst6 or
other specific protease inhibitors and subsequently in-
cubated with the probe. The resulting proteins were then
denatured, resolved on an SDS-PAGE gel and scanned for
Figure 1. Phenotype of rescued Tg(INV-Cst6)Cst6ichq/ichq mice.
A) Tg(INV-Cst6)Cst6ichq/ichq mice survived and showed periodic
hair loss. After 4 mo, the progenies became completely bald.
Keratitis and thickening of the cornea were observed in
Tg(INV-Cst6)Cst6ichq/ichqmice from 4 to 5 mo. The mice shown are
9 and 32 wk old. Inset: magniﬁed view of an affected eye. B)
Keratitis and metaplasia of the corneal epithelium in Tg(INV-
Cst6)Cst6ichq/ichq mice. H&E staining of the eye and the cornea
in WT and Tg(INV-Cst6)Cst6ichq/ichq mice. C) Immunoﬂuores-
cence staining for the expression of loricrin (LOR) and
ﬁlaggrin (FLG) in the cornea. Scale bars, 100 mm.
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fluorescence. We observed specific inhibition of mouse
CtsB by mouse Cst6, suggesting that CtsB is another
physiologic target of Cst6 (Fig. 3A). Similar results were
obtained when using B16-F10 mouse melanoma cells
(Supplemental Fig. 3). Furthermore, in a fluorometric
protease inhibitor activity enzymeassaya strong inhibition
of recombinant mouse CtsB by recombinant mouse Cst6
was observed, as reflected by Ki = 0.98 nM (Fig. 3B).
Immunolocalization ofCtsB in the skin ofmice, in a double
labeling with Cst6 revealed that CtsB is expressed in the
HF,where it colocalizeswithCst6 (Fig. 4A). Together, these
data suggest that the absence of Cst6 in the lower region of
the HFs of Tg(INV-Cst6)Cst6ichq/ichq rescued mice might
lead to uncontrolled CtsB activity (Fig. 4B) and, as a result,
destruction of the surrounding tissue and HFs (Fig. 4C).
DISCUSSION
In this report, we present in vivo evidence that Cst6 is not
only a key molecule in a biochemical pathway that con-
trols SC homeostasis but plays an additional role in
maintaining HF integrity. Biochemical and histologic
analyses suggest that unrestricted CtsB activity is re-
sponsible for disturbance of HF biology leading to the
baldness phenotype of Tg(INV-Cst6)Cst6ichq/ichq transgenic
mice. Our studies advance the understanding of the Cst6-
controlled pathways that are critical for skin barrier func-
tion (4, 7, 8, 11) andHFmaintenance (Fig. 5).Moreover,we
provide evidence that CtsB represents a novel Cst6 target.
We have demonstrated, using a Cst6/Ctsl double-
knockout approach in mice, that ablation of CtsL could
rescue the lethal skin phenotype of Cst6-deficient mice,
suggesting that CtsL is responsible for the ichthyosis
phenotypeandearly lethalityof thesemice(8).Cst62/2Ctsl+/2,
but not Cst62/2Ctsl2/2, mice developed keratitis and
squamous metaplasia of the corneal epithelium. CstB-
deficient mice display a similar eye phenotype (16), as
well. As both CstB and Cst6 are high-affinity CtsL in-
hibitors, this finding strongly supports our conclusion
that unrestricted CtsL activity is responsible for corneal
pathology. In the current study, we observed a similar
corneal phenotype (i.e., keratitis and expression of epi-
dermal differentiation markers in the corneal epithe-
lium) in rescued adult Tg(INV-Cst6)Cst6ichq/ichq mice.
Apparently, Cst6 is not reexpressed in the cornea by the
transgene, a finding corroboratedby the absence of eGFP
expression in the corneal epithelium of rescued trans-
genic mice (not shown), subsequently leading to an ex-
cess of CtsL activity. This observation is remarkable, as
Figure 2. Destruction of the HFs in Tg(INV-Cst6)Cst6ichq/ichq mice. A) Immunoﬂuorescence double labeling of INV and Cst6 in the
epidermis and the HF of WT mice. Cst6 was expressed in the stratum granulosum and halfway up the HF, including the area
around the bulge, whereas INV expression was also seen in the stratum granulosum, but remained only in the proximal part of
the HF. B) Immunohistological labeling in WT mice to detect the location of the bulge area (arrows) using the stem cell markers
CD34 and keratin 15 and the proliferation marker Ki67. C) H&E staining of Tg(INV-Cst6)Cst6ichq/ichq mice from 11, 13, and 16 wk
showed disappearance of the HFs. Scale bar, 100 mm.
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some reports suggest that INV is expressed in the normal
human (17) and mouse (18) corneal epithelium. How-
ever, we and others could not detect INV protein ex-
pression in cornea of adult WT mice (8, 19). Loss of
eyelashes, in itself, can lead to corneal irritation and is
associatedwith ocular diseases (20). As the Tg(INV-Cst6)
Cst6ichq/ichqmice develop normal eye lashes, the observed
keratitis is probably not a secondary phenotype origi-
nating from eyelash alopecia.
The observed hair loss in adult Tg(INV-Cst6)Cst6ichq/ichq
transgenicmice cannot be the consequence of unrestricted
CtsL activity, as the Cst62/2Ctsl2/2mouse is also bald (8).
Thus, other protease activities are likely to be responsible
for this phenotype. We used a qABP to identify candidate
proteases. qABPs are small-molecule tools that allow for
the monitoring and profiling of protease activities in
complex biologic systems (14, 21, 22). They form activity-
dependent covalent bonds with protease active site nu-
cleophiles and, in thismanner, canprovidea readoutof the
levels of active protease in a cell, tissue or even whole
organism (22). Protease abundance does often not directly
correlatewith activity. Therefore, the use of these qABPs is
of great interest and provides a novel method of identi-
fying new target proteases.
InWTmice, Cst6 and INV colocalize in the epidermis
and the proximal part of the HF, whereas Cst6 expres-
sion is also present in lower regions of the HF. As INV
protein expression could not be detected in this region
in WT mice, this finding means that in Tg(INV-Cst6)
Cst6ichq/ichq transgenic mice, Cst6 is not reexpressed. We
hypothesize that in this part of the HF, Cst6 has another
function or target. A plausible candidate target could be
CtsB, for which human Cst6 showed a moderate in-
hibition (2, 23, 24). CtsB is a ubiquitously expressed
cysteine protease, belonging to the papain family,
similar to CtsL (25). It has been shown to act as a
dominant protease in cellular apoptosis and senescence
and to play a role in lysosomal cathepsin–dependent
apoptosis pathways (26, 27). Whereas CtsL-deficient
mice are known for their prominent periodic hair loss
phenotype, manifesting together with epidermal hy-
perplasia, acanthosis, and hyperkeratosis (28), CtsB-
deficient mice do not display any obvious skin or fur
phenotype (29). In a recent study, the murine skin
proteome and degradome of CtsB and CtsL-deficient
micewere compared (30). Protein abundances of.1300
proteins were analyzed in skin specimens fromWT and
CtsB- and CtsL-deficient mice. Several proteins that are
associated with skin phenotypes in knockout mice
weremore abundant inCtsL-deficientmice: CtsD,Cst6,
periostin, and caspase 14. Also, CstB was significantly
more abundant. The more pronounced impact of CtsL
ablation on proteins important for mouse skin biology
corresponds to the fact that CtsL-deficient mice show an
overt skin phenotype,whileCtsB-deficientmicedonot. In
comparison, our Tg(INV-Cst6)Cst6ichq/ichq transgenic mice
modelprobably results inuncontrolledCtsBexpression in
the HFs. Altered CtsB activity correlates with several
pathologic conditions in humans, including bone and
joint disorders, pancreatitis, Alzheimer’s disease, and
metastatic cancers (31–35).Comparison ofCtsBdeficiency
and overexpression in 4 unrelated genetic mouse mod-
els of de novo tumorigenesis consistently describe CtsB
as a tumor-promoting protease and thereby, a potential
therapeutic target (36).
We speculate that unrestricted CtsB activity leads to
disturbance of HF biology, which might explain the ob-
served baldness in Tg(INV-Cst6)Cst6ichq/ichq transgenic
mice. It appears that both CtsB and CtsL are essential for
HF maintenance. Both proteases are expressed in the ex-
ternal root sheath of rat HFs (37). CTSB and CTSL are also
present in humanbulge cells andouter root sheath cells, as
Figure 3. Inhibition of mouse CtsB by mouse Cst6. A) BMV109 labels active cysteine cathepsins, such as CTSB and CTSX (14) in
RAW cell lysates (murine macrophage cell line). Lane 1, no inhibitor; lane 2, JPM-OEt (pan-cathepsin inhibitor, 50 mM); lane 3,
CA-074 (CtsB inhibitor, 10 mM); lane 4, Z-FY (t-BU)DMK (CtsL inhibitor, 10 mM); lane 5, mouse Cst6 (18 mM); and lane 6, heat
inactivation. Note that CA-074 and Cst6 inhibited CtsB (lane 3 and 5). M = precision plus protein dual-color marker. B) The Ki for
the inhibition of CtsB by Cst6 was determined by measuring the residual enzymatic activity of a ﬁxed concentration of enzyme,
incubated with increasing concentrations of the inhibitor. An Easson-Stedman plot (inset) was used to calculate the Ki, according
to the equation [I]/1 2 a = (Ki/a) + E
0, were I is the inhibitor concentration, E0 is the enzyme concentration at time 0, and a is
the fractional activity. The plot yielded a straight line with a Ki slope of 0.98 nM.
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identified by cDNA microarrays (38). Both proteases can
be regulated by CST6, but also by other cathepsins. The
major, general extracellular cysteine protease inhibitor
CSTC is a high-affinity inhibitor of CTSB (39), whereas
CSTA is amoderate CTSB inhibitor (40). CSTA, -B, -C, and
-F are all high-affinity CTSL inhibitors (4). Although
CSTA, C, andM/E are all present in outer root sheath and
HF bulge cells, only CST6 is significantly overrepresented
in this area (7-fold change) (38). Therefore, CST6 is well
suited to play an important role inHFmaintenance, likely
by controlling CTSB activity.
The present study further expands our understanding
of the role of Cst6 in complex proteolytic pathways that
maintain skin barrier function and HF morphogenesis.
Based on the phenotypes of the knockout (Cst62/2 and
Cst62/2Ctsl2/2) and rescued (Tg(INV-Cst6)Cst6ichq/ichq)
Figure 4. CtsB and Cst6 colocalize in the mouse HF. A) Immunoﬂuorescence double staining for Cst6 (green) and CtsB
(red) in WT mice revealed that colocalization of both proteins was found in the proximal part of the HF as well as the lower
region where the bulge area resides. Cst6 is also expressed in the epidermis, whereas no CtsB is observed. Scale bar, 100 mm.
B) Cst6 and CtsB expression in mouse epidermis and HFs of Tg(INV-Cst6)Cst6ichq/ichq mice. No immunoﬂuorescence
staining for Cst6 was observed in the lower region of the HF (close to the bulge, arrowheads). Scale bar, 100 mm. C )
Schematic presentation of INV, Cst6, and CtsB localization in the HF and epidermis of WT mice and the situation in rescued
transgenic Tg(INV-Cst6)Cst6ichq/ichq mice.
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transgenic mice, Cst6 and the other components of pro-
teolytic pathways in skin and HFs represent candidate
genes for human disorders of cornification and HF in-
tegrity. Whether CST6 and its target proteases are in-
volved in various congenital or acquired forms of hair loss
in humans, like different forms of alopecia (41), remains to
be investigated.
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